T1	Pharmacological_substance 9 18	Bleomycin
N1000 	Reference T1 MeSH:D001761	Bleomycin
N1001 	Reference T1 MeSH:C047120	Bleomycin
T2	Pharmacological_substance 23 39	cyclophosphamide
N1002 	Reference T2 MeSH:D003520	cyclophosphamide
T3	Disorder 40 48	toxicity
N1 	Reference T3 UMLS:C0600688	toxicity
T4	Disorder 105 111	cancer
N2 	Reference T4 UMLS:C0006826	cancer
N3 	Reference T4 UMLS:C1306459	cancer
T5	Disorder 151 166	Ewing's sarcoma
N4 	Reference T5 UMLS:C0553580	Ewing's sarcoma
T6	Disorder 186 201	germ cell tumor
N5 	Reference T6 UMLS:C0205851	germ cell tumor
T7	Pharmacological_substance 248 257	bleomycin
N1003 	Reference T7 MeSH:D001761	bleomycin
N1004 	Reference T7 MeSH:C047120	bleomycin
T8	Pharmacological_substance 261 277	cyclophosphamide
N1005 	Reference T8 MeSH:D003520	cyclophosphamide
T9	Disorder 481 497	fibrotic lesions
T10	Pharmacological_substance 525 534	bleomycin
N1006 	Reference T10 MeSH:D001761	bleomycin
N1007 	Reference T10 MeSH:C047120	bleomycin
T11	Pharmacological_substance 538 554	cyclophosphamide
N1008 	Reference T11 MeSH:D003520	cyclophosphamide
T12	Subject 114 145	Two pediatric oncology patients
T14	Disorder 453 463	metastasis
N6 	Reference T14 UMLS:C2939419	metastasis
T15	Disorder 593 610	pulmonary lesions
N7 	Reference T15 UMLS:C0577916	pulmonary lesions
T16	Subject 624 642	all three patients
T17	Disorder 738 755	pulmonary nodules
N8 	Reference T17 UMLS:C0748164	pulmonary nodules
T19	Subject 95 104	childhood
T20	Disorder 60 78	metastatic nodules
